Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 7/2011

01-07-2011 | Symposium: AAOS/ORS/ABJS Musculoskeletal Healthcare Disparities Research Symposium

Optimizing Screening for Osteoporosis in Patients With Fragility Hip Fracture

Authors: Archana Roy, MD, Michael G. Heckman, MSc, Mary I. O’Connor, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 7/2011

Login to get access

Abstract

Background

Osteoporosis, the underlying cause of most hip fractures, is underdiagnosed and undertreated. The 2008 Joint Commission report Improving and Measuring Osteoporosis Management showed only an average of 20% of patients with low-impact fracture are ever tested or treated for osteoporosis. We developed an integrated model utilizing hospitalists and orthopaedic surgeons to improve care of osteoporosis in patients with hip fracture.

Questions/purposes

Does our integrated model combining hospitalists and orthopaedic surgeons improve the frequency of evaluation for osteoporosis, screening for secondary causes, and patients’ education on osteoporosis?

Patients and Methods

Our Hospitalist-Orthopaedic Surgeon Integrated Model of Care was implemented in September 2009. We compared the rate of evaluation and treatment of osteoporosis in 140 patients admitted with fragility hip fracture at our institution before (70 patients) and after (70 patients) implementation of the care plan.

Results

Evaluation of patients for osteoporosis was higher in the postimplementation group compared to the preimplementation group (89% versus 24%). Screening of patients for secondary causes of osteoporosis was also improved in the postimplementation group (89% versus 0%), as was the proportion of patients who received education for osteoporosis management (89% versus 0%).

Conclusion

Our model of integrated care by hospitalists and orthopaedic surgeons resulted in improvement in the evaluation for osteoporosis, screening for secondary causes of osteoporosis, and education on osteoporosis management in patients with hip fracture at our institution. This may have important implications for treatment of these patients.

Level of Evidence

Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
go back to reference Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.PubMedCrossRef Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.PubMedCrossRef
2.
go back to reference Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int. 2000;11:556–561.PubMedCrossRef Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int. 2000;11:556–561.PubMedCrossRef
3.
go back to reference George A, Tracy JK, Meyer WA, Flores RH, Wilson PD, Hochberg MC. Racial differences in bone mineral density in older men. J Bone Miner Res. 2003;18:2238–2244.PubMedCrossRef George A, Tracy JK, Meyer WA, Flores RH, Wilson PD, Hochberg MC. Racial differences in bone mineral density in older men. J Bone Miner Res. 2003;18:2238–2244.PubMedCrossRef
4.
go back to reference Heaney RP. Bone mass, bone loss, and osteoporosis prophylaxis. Ann Intern Med. 1998;128:313–314.PubMed Heaney RP. Bone mass, bone loss, and osteoporosis prophylaxis. Ann Intern Med. 1998;128:313–314.PubMed
5.
go back to reference Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med. 2008;149:751–760.PubMed Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med. 2008;149:751–760.PubMed
6.
go back to reference Kennel KA, Drake MT. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc. 2009;84:632–637; quiz 638.PubMedCrossRef Kennel KA, Drake MT. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc. 2009;84:632–637; quiz 638.PubMedCrossRef
7.
go back to reference Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol. 2009;23:769–779.PubMedCrossRef Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol. 2009;23:769–779.PubMedCrossRef
8.
go back to reference Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Goldberg J. Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1997;146:502–509.PubMed Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Goldberg J. Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1997;146:502–509.PubMed
9.
go back to reference Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761–1768.PubMedCrossRef Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761–1768.PubMedCrossRef
10.
go back to reference National Osteoporosis Foundation. America’s Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation; 2002. National Osteoporosis Foundation. America’s Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation; 2002.
11.
go back to reference National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
12.
go back to reference Nelson DA, Jacobsen G, Barondess DA, Parfitt AM. Ethnic differences in regional bone density, hip axis length, and lifestyle variables among healthy black and white men. J Bone Miner Res. 1995;10:782–787.PubMedCrossRef Nelson DA, Jacobsen G, Barondess DA, Parfitt AM. Ethnic differences in regional bone density, hip axis length, and lifestyle variables among healthy black and white men. J Bone Miner Res. 1995;10:782–787.PubMedCrossRef
13.
go back to reference Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010;153:99–111.PubMed Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010;153:99–111.PubMed
14.
go back to reference Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA. 1990;263:2335–2340.PubMedCrossRef Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA. 1990;263:2335–2340.PubMedCrossRef
15.
go back to reference The Joint Commission. Improving and Measuring Osteoporosis Management. Oakbrook Terrace, IL: The Joint Commission; 2007. The Joint Commission. Improving and Measuring Osteoporosis Management. Oakbrook Terrace, IL: The Joint Commission; 2007.
16.
go back to reference US Department of Health and Human Services, Office of the Surgeon General. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004. US Department of Health and Human Services, Office of the Surgeon General. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004.
Metadata
Title
Optimizing Screening for Osteoporosis in Patients With Fragility Hip Fracture
Authors
Archana Roy, MD
Michael G. Heckman, MSc
Mary I. O’Connor, MD
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 7/2011
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-011-1839-5

Other articles of this Issue 7/2011

Clinical Orthopaedics and Related Research® 7/2011 Go to the issue

Symposium: AAOS/ORS/ABJS Musculoskeletal Healthcare Disparities Research Symposium

Does a Multidisciplinary Team Decrease Complications in Male Patients With Hip Fractures?

Symposium: AAOS/ORS/ABJS Musculoskeletal Healthcare Disparities Research Symposium

Gender and Race/Ethnicity Differences in Hip Fracture Incidence, Morbidity, Mortality, and Function

Symposium:AAOS/ORS/ABJS Musculoskeletal Healthcare Disparities Research Symposium

Keynote Address: The Need for Greater Racial and Ethnic Diversity in Orthopaedic Surgery